CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes
| | | | | Tissue enhanced |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes
| | | | | Tissue enhanced |
CCK | Cholecystokinin | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL24 | Chemokine (C-C motif) ligand 24 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD70 | CD70 molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CEA | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4F | C-type lectin domain family 4, member F | Predicted membrane proteins
| | | | | Tissue enhanced |
CLIC6 | Chloride intracellular channel 6 | Transporters
| | | | | Tissue enhanced |
COL2A1 | Collagen, type II, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COLCA1 | Colorectal cancer associated 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CRYBA2 | Crystallin, beta A2 | Disease related genes
| | | | | Tissue enhanced |
CTD-2545M3.6 | | | | | | | Tissue enhanced |
CXCL17 | Chemokine (C-X-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2W1 | Cytochrome P450, family 2, subfamily W, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP3A5 | Cytochrome P450, family 3, subfamily A, polypeptide 5 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | | | | | | Tissue enhanced |
DCHS2 | Dachsous cadherin-related 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
DHRS9 | Dehydrogenase/reductase (SDR family) member 9 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enhanced |
EDN2 | Endothelin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
EFNA2 | Ephrin-A2 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ENPP3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | CD markers Enzymes
| | | | | Tissue enhanced |
ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPN3 | Epsin 3 | | | | | | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | | | | | | Tissue enhanced |
FA2H | Fatty acid 2-hydroxylase | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FADS6 | Fatty acid desaturase 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM132A | Family with sequence similarity 132, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM177B | Family with sequence similarity 177, member B | | | | | | Tissue enhanced |
FAM211A | Family with sequence similarity 211, member A | | | | | | Tissue enhanced |
FAM3B | Family with sequence similarity 3, member B | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM3D | Family with sequence similarity 3, member D | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM83E | Family with sequence similarity 83, member E | | | | | | Tissue enhanced |